Filing Details

Accession Number:
0001225208-22-003299
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-24 16:21:53
Reporting Period:
2022-02-22
Accepted Time:
2022-02-24 16:21:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529751 A David Pierce 300 Boston Scientific Way
Marlborough MA 01752-1234
Evp Pres Medsurg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-22 1,884 $42.55 1,761 No 4 S Direct
Common Stock Disposition 2022-02-23 1,761 $43.28 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Share Units Acquisiton 2022-02-22 17,439 $0.00 17,439 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,439 2023-12-31 2023-12-31 No 4 A Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
  2. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  3. On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2023.